Abstract
A 43-year-old man presented with a two month history of intermittent fevers and diarrhea. He was diagnosed with human immunodeficiency virus (HIV) infection and over the ensuing seven years had not been regularly compliant with his highly active antiretroviral therapy (HAART). Past medical history was significant for hypertension, type 2 diabetes mellitus, and a poorly defined seizure disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Frisch M, Biggar RJ, Engels EA et al (2001) Association of cancer with AIDS-related immunosuppression in adults. JAMA 285:1736–1745
Ryan JL, Fan H, Glaser SL et al (2004) Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments. J Mol Diagn 6:378–385
Puren A, Gerlach JL, Weigl BH et al (2010) Laboratory operations, specimen processing, and handling for viral load testing and surveillance. J Infect Dis 201(S1):S27–S36
Broccolo F, Bossolasco S, Careddu AM et al (2002) Detection of DNA of lymphotropic herpesviruses in plasma of human immunodeficiency virus-infected patients: frequency and clinical significance. Clin Diagn Lab Immunol 9:1222–1228
Natarajan V, Bosche M, Metcalf JA et al (1999) HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy. Lancet 353:119–120
Fan H, Gulley ML (2001) Epstein-Barr viral load measurement as a marker of EBV-related disease. Mol Diagn 6:279–289
Savoldo B, Rooney CM, Di Stasi A et al (2007) Epstein Barr virus-specific cytotoxic T lymphocytes expression the anti-CD30? artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease. Blood 110:2620–2630
Helsop HE, Slobod KS, Pule MA et al (2010) Long-term outcome of EBV-related lymphoproliferative disease in transplant recipients. Blood 115:923–935
Mbulaiteye SM, Biggar RJ, Goedert JJ et al (2003) Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr 32:527–533
Burgi A, Brodine S, Wedner S et al (2005) Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer 104:1505–1511
Bedimo RJ, McGinnis DA, Dunlap M et al (2009) Incidence of non-ADIS-defining malignancies in the HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr 52:203–208
Tirelli U, Errante D, Colcetti R et al (1995) Hodgkin’s disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 13:1758–1767
Engels EA, Biggar RJ, Hall HI et al (2008) Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 123:187–194
Grogg KL, Miller RF, Dogan A (2007) HIV infection and lymphoma. J Clin Pathol 60:1365–1372
Dolcetti R, Biocchi M, Gloghini A et al (2001) Pathologic and histogenetic features of HIV-associated Hodgkin’s disease. Eur J Cancer 37:1276–1287
Hummerl M, Anagnostopoulos I, Dallenbach F et al (1995) EBV infection patterns in Hodgkin’s disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br J Haematol 175:263–271
Carbone A, Cesarman E, Spina M et al (2009) HIV-associated lymphomas and gamma-herperviruses. Blood 113:1213–1224
Mosialos G, Birkenbach M, Yalamanchili R et al (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389–399
Rastelli J, Homig-Holzel C, Seagal J et al (2008) LMP1 signal can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1. Blood 111:1448–1455
Gandhi MK, Lambley E, Burrows J et al (2006) Plasma Epstein-Barr virus (EBV) DNA is a biomarker for ÂEBV-positive Hodgkin’s lymphoma. Clin Cancer Res 12:460–464
Recommended Reading
Carbone A, Gloghini A, Serraino D et al (2009) HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS 4:3–10
Fan H, Kim SC, Chima CO et al (2005) Epstein-Barr viral load as a marker of lymphoma in AIDS patients. J Med Virol 75:59–69
Gulley ML (2001) Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn 3:1–10
Gulley ML, Tang W (2008) Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn 10:279–292
Gulley ML, Tang W (2010) Using Epstein-Barr viral load assays to diagnose, monitor, and prevent post-transplant lymphoproliferative disorder. Clin Microbiol Rev 23:350–366
Raphael M, Said J, Borisch B et al (2008) Lymphomas associated with HIV infection. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (eds) World Health Organization classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC Press, Lyon
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fedoriw, G., Gulley, M.L. (2011). HIV-Associated Hodgkin Lymphoma. In: Schrijver, I. (eds) Diagnostic Molecular Pathology in Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19677-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-19677-5_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-19676-8
Online ISBN: 978-3-642-19677-5
eBook Packages: MedicineMedicine (R0)